The DOI matches its Crossref record; 152 of the 152 references it cites were found in a registry or an index.
The burden of severe depression: A review of diagnostic challenges and treatment alternatives
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
A new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Koretz, D., Merikangas, K. R., Rush, A. J., Walters, E. E., & Wang, P. S. (2003) · JAMA · doi:10.1001/jama.289.23.3095 · Cited by 7,988
Deep Brain Stimulation for Treatment-Resistant Depression
Mayberg, H. S., Lozano, A. M., Voon, V., McNeely, H. E., Seminowicz, D., Hamani, C., Schwalb, J. M., & Kennedy, S. H. (2005) · Neuron · doi:10.1016/j.neuron.2005.02.014 · Cited by 4,059 · cited 3×
“Non-pharmacologic options also exist such as electroconvulsive therapy (ECT), vagus nerve stimulation (VNS), transcranial magnetic stimulation (TMS), and deep brain stimulation (DBS).”
Background(2003) · The Lancet · doi:10.1016/s0140-6736(03)12705-5 · Cited by 1,706
Keller, M. B., McCullough, J. P., Klein, D. N., Arnow, B., Dunner, D. L., Gelenberg, A. J., Markowitz, J. C., Nemeroff, C. B., Russell, J. M., Thase, M. E., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005183422001 · Cited by 1,331 · cited 1×
“The efficacy of nefazodone for the treatment of chronic depression was demonstrated in a 12-week multicenter trial in which chronically depressed (HAMD > 20) non-psychotic outpatients received nefazodone, cognitive-behavioral psychotherapy, or both (Keller et al., 2000).”
BackgroundSelf-citationKaton, W. J. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00273-7 · Cited by 1,223
Vagus nerve stimulation therapy for partial-onset seizures: A randomized active-control trial
Handforth, A., DeGiorgio, C. M., Schachter, S. C., Uthman, B. M., Naritoku, D. K., Tecoma, E. S., Henry, T. R., Collins, S. D., Vaughn, B. V., Gilmartin, R. C., et al. (1998) · Neurology · doi:10.1212/wnl.51.1.48 · Cited by 1,107
Bupropion-SR, Sertraline, or Venlafaxine-XR after Failure of SSRIs for Depression
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Stewart, J. W., Nierenberg, A. A., Thase, M. E., Ritz, L., Biggs, M. M., Warden, D., Luther, J. F., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052963 · Cited by 1,033
Medication Augmentation after the Failure of SSRIs for Depression
Trivedi, M. H., Fava, M., Wisniewski, S. R., Thase, M. E., Quitkin, F., Warden, D., Ritz, L., Nierenberg, A. A., Lebowitz, B. D., Biggs, M. M., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052964 · Cited by 1,002
Anderson, I. M. (2000) · Journal of Affective Disorders · doi:10.1016/s0165-0327(99)00092-0 · Cited by 940
(2012) · Psychiatry in Dissent · doi:10.4324/9780203714935-12 · Cited by 909
Keller, M. B. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820100053010 · Cited by 864
Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors
Thase, M. E., Entsuah, A. R., & Rudolph, R. L. (2001) · British Journal of Psychiatry · doi:10.1192/bjp.178.3.234 · Cited by 801
Rush, A. J., George, M. S., Sackeim, H. A., Marangell, L. B., Husain, M. M., Giller, C., Nahas, Z., Haines, S., Simpson, R. K., & Goodman, R. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00304-2 · Cited by 688
Sackeim, H. A., Haskett, R. F., Mulsant, B. H., Thase, M. E., Mann, J. J., Pettinati, H. M., Greenberg, R. M., Crowe, R. R., Cooper, T. B., & Prudic, J. (2001) · JAMA · doi:10.1001/jama.285.10.1299 · Cited by 686
Ben‐Menachem, E., Mañon‐Espaillat, R., Ristanovic, R., Wilder, B. J., Stefan, H., Mirza, W., Tarver, W. B., Wernicke, J. F., & First International Vagus Nerve Stimulation Study Group (1994) · Epilepsia · doi:10.1111/j.1528-1157.1994.tb02482.x · Cited by 683
Psychosocial Disability During the Long-term Course of Unipolar Major Depressive Disorder
Judd, L. L., Akiskal, H. S., Zeller, P. J., Paulus, M., Leon, A. C., Maser, J. D., Endicott, J., Coryell, W., Kunovac, J. L., Mueller, T. I., et al. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.4.375 · Cited by 593
Textbook of psychopharmacology
Edwards, G. (1975) · Nature · doi:10.1038/258648b0 · Cited by 585
Sackeim, H. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00271-8 · Cited by 568
Treatment of major depression with psychotherapy or psychotherapy-pharmacotherapy combinations
Thase, M. E. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830230043006 · Cited by 515
Efficacy of ECT in Depression: A Meta-Analytic Review
Pagnin, D., de Queiroz, V., Pini, S., & Cassano, G. B. (2004) · The Journal of ECT · doi:10.1097/00124509-200403000-00004 · Cited by 509
A Novel Augmentation Strategy for Treating Resistant Major Depression
Shelton, R. C., Tollefson, G. D., Tohen, M., Stahl, S., Gannon, K. S., Jacobs, T. G., Buras, W. R., Bymaster, F. P., Zhang, W., Spencer, K. A., et al. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.1.131 · Cited by 504
Social and economic burden of mood disorders
Simon, G. E. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00420-7 · Cited by 429
(1990) · Journal of Affective Disorders · doi:10.1016/0165-0327(90)90081-i · Cited by 395
Weight gain and antidepressants.
D, M. F. M. (2000) · PubMed · Cited by 388
Buckley, N. A., & McManus, P. R. (2002) · BMJ · doi:10.1136/bmj.325.7376.1332 · Cited by 380
Goldberg, J. F., Burdick, K. E., & Endick, C. J. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.3.564 · Cited by 372
Lithium Induces Rapid Relief of Depression in Tricyclic Antidepressant Drug Non-Responders
Dé Montigny, C., Grunberg, F., Mayer, A., & Deschenes, J.-P. (1981) · British Journal of Psychiatry · doi:10.1192/bjp.138.3.252 · Cited by 367
Pramipexole for bipolar II depression: a placebo-controlled proof of concept study
Zarate, C. A., Payne, J. L., Singh, J., Quiroz, J. A., Luckenbaugh, D. A., Denicoff, K. D., Charney, D. S., & Manji, H. K. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.03.013 · Cited by 347
Duloxetine in the Treatment of Major Depressive Disorder: A Double-Blind Clinical Trial
Goldstein, D. J., Mallinckrodt, C., Lu, Y., & Demitrack, M. A. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0309 · Cited by 334
Trivedi, M. H., Rush, A. J., Crismon, M. L., Kashner, T. M., Toprac, M. G., Carmody, T. J., Key, T., Biggs, M. M., Shores-Wilson, K., Witte, B., et al. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.7.669 · Cited by 316
Goldstein, D. J., Lu, Y., Detke, M. J., Wiltse, C., Mallinckrodt, C., & Demitrack, M. A. (2004) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000132448.65972.d9 · Cited by 314
Grunhaus, L., Dannon, P. N., Schreiber, S., Dolberg, O. H., Amiaz, R., Ziv, R., & Lefkifker, E. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00254-1 · Cited by 306
Citalopram: Clinical effect profile in comparison with clomipramine. A controlled multicenter study
Gram, L. (1986) · Psychopharmacology · doi:10.1007/bf00172884 · Cited by 301
de Montigny, C. (1983) · Archives of General Psychiatry · doi:10.1001/archpsyc.1983.01790110069012 · Cited by 300
Clerc, G. E., Ruimy, P., & Verdeau-Paillès, J. (1994) · International Clinical Psychopharmacology · doi:10.1097/00004850-199409000-00001 · Cited by 298
Nelson, J. C. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810280019002 · Cited by 294
Vagus nerve stimulation (VNS) for major depressive episodes: one year outcomes
Marangell, L. B., Rush, A. J., George, M. S., Sackeim, H. A., Johnson, C. R., Husain, M. M., Nahas, Z., & Lisanby, S. H. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01343-9 · Cited by 290
Relative mortality from overdose of antidepressants
Henry, J. A., Alexander, C. A., & Sener, E. K. (1995) · BMJ · doi:10.1136/bmj.310.6974.221 · Cited by 290
(1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.12.1735 · Cited by 285
Antidepressant-related deaths and antidepressant prescriptions in England and Wales, 1998–2000
Cheeta, S., Schifano, F., Oyefeso, A., Webb, L., & Ghodse, A. H. (2004) · British Journal of Psychiatry · doi:10.1192/bjp.184.1.41 · Cited by 284
Müller, M. (2003) · Journal of Affective Disorders · doi:10.1016/s0165-0327(02)00120-9 · Cited by 282 · cited 1×
“In an empirical study to validate the MADRS cut-off scores to define severe depression, best separation between moderate and severe depression occurred with a MADRS score of P31 (Muller et al., 2003).”
BackgroundDetke, M. J., Wiltse, C. G., Mallinckrodt, C. H., McNamara, R. K., Demitrack, M. A., & Bitter, I. (2004) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2004.01.002 · Cited by 282
Association Between Depressive Symptoms and Mortality in Older Women
Whooley, M. A. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.19.2129 · Cited by 270
Anderson, I. M. (1998) · Depression and Anxiety · doi:10.1002/(sici)1520-6394(1998)7:1+<11::aid-da4>3.0.co;2-i · Cited by 266
Altshuler, L. L., Bauer, M., Frye, M. A., Gitlin, M. J., Mintz, J., Szuba, M. P., Leight, K. L., & Whybrow, P. C. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.10.1617 · Cited by 250 · cited 1×
“A meta-analysis of six placebo-controlled trials for unipolar depressive disorder suggested significant effects for T3 in accelerating TCA response (Altshuler et al., 2001).”
MethodRisperidone Augmentation of Selective Serotonin Reuptake Inhibitors in Major Depression
Ostroff, R. B., & Nelson, J. C. (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0410 · Cited by 248
Effects of Paroxetine and Venlafaxine XR on Heart Rate Variability in Depression
Davidson, J., Watkins, L., Owens, M., Krulewicz, S., Connor, K., Carpenter, D., Krishnan, R., & Nemeroff, C. (2005) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000177547.28961.03 · Cited by 239
Self-citationRECOVERY, CHRONICITY, AND LEVELS OF PSYCHOPATHOLOGY IN MAJOR DEPRESSION
Mueller, T. I., & Leon, A. C. (1996) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(05)70275-6 · Cited by 234
Kennedy, S. H., Andersen, H. F., & Lam, R. W. (2006) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0615 · Cited by 216
Double-Blind, Randomized Comparison of Mirtazapine and Paroxetine in Elderly Depressed Patients
Schatzberg, A. F., Kremer, C., Rodrigues, H. E., & Murphy, G. M. (2002) · The American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200209000-00007 · Cited by 215 · cited 2×
“…daily dose at endpoint 34 mg) and paroxetine (n = 120, mean daily dose at endpoint 33.6 mg) in elderly patients (P65 years old) with major depression revealed that mirtazapine displayed a more rapid onset of action than did paroxetine (28% versus 13% responded at 2 weeks) (Schatzberg et al., 2002).”
BackgroundInfluentialPredictors of an acute antidepressant response to fluoxetine and sertraline
Flament, M. F., Lane, R. M., Zhu, R., & Ying, Z. (1999) · International Clinical Psychopharmacology · doi:10.1097/00004850-199909000-00001 · Cited by 209
A double-blind placebo-controlled trial of milnacipran in the treatment of fibromyalgia
Vitton, O., Gendreau, M., Gendreau, J., Kranzler, J., & Rao, S. G. (2004) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.622 · Cited by 202
Janicak, P. G., Dowd, S. M., Martis, B., Alam, D., Beedle, D., Krasuski, J., Strong, M. J., Sharma, R., Rosen, C., & Viana, M. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01354-3 · Cited by 190
Nelson, J. C., Mazure, C. M., Jatlow, P. I., Bowers, M. B., & Price, L. H. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.08.007 · Cited by 189
Moore, N., Verdoux, H., & Fantino, B. (2005) · International Clinical Psychopharmacology · doi:10.1097/00004850-200505000-00002 · Cited by 188
An overview of the clinical efficacy of mirtazapine
Benkert, O., Muller, M., & Szegedi, A. (2002) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.397 · Cited by 179
On tyramine, food, beverages and the reversible MAO inhibitor moclobemide.
Prada, M. D., Zürcher, G., Wüthrich, I., & Haefely, W. E. (1988) · PubMed · Cited by 176
Duloxetine for the Treatment of Major Depressive Disorder
Nemeroff, C. B., MD, PhD, Schatzberg, A. F., MD, Goldstein, D. J., MD, PhD, Detke, M. J., MD, et al. (2025) · Psychopharmacology Bulletin · doi:10.64719/pb.4207 · Cited by 175
Self-citationA Comparison of Paroxetine, Imipramine and Placebo in Depressed Out-patients
Dunbar, G. C., Cohn, J. B., Fabre, L. F., Feighner, J. P., Fieve, R. R., Mendels, J., & Shrivastava, R. K. (1991) · British Journal of Psychiatry · doi:10.1192/bjp.159.3.394 · Cited by 175
Effectiveness of venlafaxine in patients hospitalized for major depression and melancholia.
Guelfi, J., White, C. M., Hackett, D., Guichoux, J. Y., & Magni, G. (1995) · PubMed · Cited by 170
Gorman, J. M., Korotzer, A., & Su, G. (2002) · CNS Spectrums · doi:10.1017/s1092852900028595 · Cited by 169
Efficacy of SSRIs and Newer Antidepressants in Severe Depression: Comparison With TCAs
Hirschfeld, R. M. A. (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0511 · Cited by 168
Zimmerman, M. A., Chelminski, I., & Posternak, M. A. (2004) · The Journal of Nervous and Mental Disease · doi:10.1097/01.nmd.0000138226.22761.39 · Cited by 162
Yoshida, K., Takahashi, H., Higuchi, H., Kamata, M., Ito, K.-I., Sato, K., Naito, S., Shimizu, T., Itoh, K., Inoue, K., et al. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.9.1575 · Cited by 160
Self-citationWheatley, D. P., Moffaert, M. V., Timmerman, L., & Kremer, C. M. E. (1998) · PubMed · Cited by 157
Mirtazapine Compared With Paroxetine in Major Depression
Benkert, O., Szegedi, A., & Kohnen, R. (2000) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v61n0911 · Cited by 157
Appelberg, B., Syvälahti, E. K. G., Koskinen, T., Mehtonen, O. ‐., Muhonen, T. T., & Naukkarinen, H. (2001) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v62n0608 · Cited by 155
BOLD-f MRI response to single-pulse transcranial magnetic stimulation (TMS)
Bohning, D. E., Shastri, A., Wassermann, E. M., Ziemann, U., Lorberbaum, J. P., Nahas, Z. H., Lomarev, M. P., & George, M. S. (2000) · Journal of Magnetic Resonance Imaging · doi:10.1002/1522-2586(200006)11:6<569::aid-jmri1>3.0.co;2-3 · Cited by 149
Papakostas, G. I., Petersen, T., Nierenberg, A. A., Murakami, J. L., Alpert, J. E., Rosenbaum, J. F., & D, M. F. M. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0212 · Cited by 148
Leinonen, E., Skarstein, J., Behnke, K., ??gren, H., & Th Helsdingen, J. (1999) · International Clinical Psychopharmacology · doi:10.1097/00004850-199911000-00002 · Cited by 146
Double-Blind, Randomized Comparison of Mirtazapine and Paroxetine in Elderly Depressed Patients
Schatzberg, A. F. (2002) · American Journal of Geriatric Psychiatry · doi:10.1176/appi.ajgp.10.5.541 · Cited by 146
Wheatley, D. P., van Moffaert, M., Timmerman, L., Kremer, C. M. E., & The Mirtazapine-Fluoxetine Study Group (1998) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v59n0606 · Cited by 145
Mirtazapine Versus Venlafaxine in Hospitalized Severely Depressed Patients With Melancholic Features
Guelfi, J. D., Ansseau, M., Timmerman, L., & Kørsgaard, S. (2001) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200108000-00010 · Cited by 138
Venlafaxine Versus Fluvoxamine in the Treatment of Delusional Depression
Zanardi, R., Franchini, L., Serretti, A., Pérez, J., & Smeraldi, E. (2000) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v61n0107 · Cited by 134
Depression, IV: STAR*D Treatment Trial for Depression
Rush, A. J., Trivedi, M. H., & D, M. F. M. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.2.237 · Cited by 126
Milnacipran and selective serotonin reuptake inhibitors in major depression
López-Ibor, J. J., Guelfi, J., Plétan, Y., Tournoux, A., & Prost, J. F. (1996) · International Clinical Psychopharmacology · doi:10.1097/00004850-199609004-00006 · Cited by 126
Thase, M. E., Frank, E., Mallinger, A. G., Hamer, T., & Kupfer, D. J. (1992) · PubMed · Cited by 114
Keitner, G. I., Garlow, S. J., Ryan, C. E., Ninan, P. T., Solomon, D. A., Nemeroff, C. B., & Keller, M. B. (2009) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2008.05.003 · Cited by 108
Self-citationBenkert, O., Gründer, G., Wetzel, H., & Hackett, D. (1996) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(96)00029-5 · Cited by 105
Barbee, J. G., Conrad, E. J., & Jamhour, N. J. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0714 · Cited by 104
Simon, J. S., & Nemeroff, C. B. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n1002 · Cited by 103
Self-citationGutierrez, M. A., Stimmel, G. L., & Aiso, J. Y. (2003) · Clinical Therapeutics · doi:10.1016/s0149-2918(03)80210-2 · Cited by 102
Hausmann, A., Kemmler, G., Walpoth, M., Mechtcheriakov, S., Kramer-Reinstadler, K., Lechner, T., Walch, T., Deisenhammer, E., Köfler, M., Rupp, C. I., et al. (2004) · PubMed Central · Cited by 99
Essentials of Clinical Psychopharmacology
(2006) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781585623167 · Cited by 97
Silva, J. C. E. (1998) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v59n0703 · Cited by 95
Severe Depression: Is There a Best Approach?
Sonawalla, S. B., & D, M. F. M. (2001) · CNS Drugs · doi:10.2165/00023210-200115100-00003 · Cited by 91
Clinical experience with dual action antidepressants in different chronic pain syndromes
Briley, M. (2004) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.621 · Cited by 86
Treatment of depression in patients with heart disease
Roose, S. P. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00320-2 · Cited by 81
Clinical efficacy of mirtazapine: a review of meta-analyses of pooled data
Kasper, S. F. (1995) · International Clinical Psychopharmacology · doi:10.1097/00004850-199512004-00005 · Cited by 80
Catafau, A. M., Pérez, V., Gironell, A., Martin, J. C., Kulisevsky, J., Estorch, M., Carrió, I., & Álvarez, E. (2001) · Psychiatry Research Neuroimaging · doi:10.1016/s0925-4927(01)00079-8 · Cited by 77
Nemeroff, C. B., & Thase, M. E. (2005) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2005.07.009 · Cited by 76
Self-citationMechanisms and the Current State of Deep Brain Stimulation in Neuropsychiatry
Greenberg, B. D., & Rezai, A. R. (2003) · CNS Spectrums · doi:10.1017/s109285290001899x · Cited by 76
PRIDMORE, S. A. (2000) · Depression and Anxiety · Cited by 75
Efficacy of escitalopram in patients with severe depression: a pooled analysis
Llorca, P., Azorin, J., Despiégel, N., & Verpillat, P. (2005) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2005.00440.x · Cited by 74
Braconnier, A., Coent, R. L., & Cohen, D. (2003) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200301000-00007 · Cited by 73
Reimherr, F. W., Cunningham, L. A., Batey, S. R., Johnston, J. A., & Ascher, J. A. (1998) · Clinical Therapeutics · doi:10.1016/s0149-2918(98)80060-x · Cited by 72
Depression With Atypical Features: Diagnostic Validity, Prevalence, and Treatment
Quitkin, F. M. (2002) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.v04n0302 · Cited by 71
Segal, Z. V., Vincent, P., & LEVITT, A. J. (2002) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0246 · Cited by 70
Schlaepfer, T. E., Kosel, M., & Nemeroff, C. B. (2002) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300038 · Cited by 70
Self-citationTreatment of severe depression.
Thase, M. E. (2000) · PubMed · Cited by 68
Clerc, G. (2001) · International Clinical Psychopharmacology · doi:10.1097/00004850-200105000-00003 · Cited by 67
Cardiovascular and neurological toxicity of venlafaxine
Blythe, D., & Hackett, L. P. (1999) · Human & Experimental Toxicology · doi:10.1191/096032799678840165 · Cited by 67
Duloxetine: A New Treatment for the Emotional and Physical Symptoms of Depression
Mallinckrodt, C. H., GOLDSTEIN, D. J., Detke, M. J., Lu, Y., & Trân, P. V. (2003) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.v05n0105 · Cited by 65
Treatment-Resistant Depression
Ananth, J. (1998) · Psychotherapy and Psychosomatics · doi:10.1159/000012261 · Cited by 64
Fluoxetine and Desipramine in Major Depressive Disorder
Bowden, C. L., Schatzberg, A. F., ROSENBAUM, A., Contreras, S. A., SAMSON, J. A., Dessain, E. C., & Sayler, M. E. (1993) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199310000-00002 · Cited by 64
Triiodothyronine Addition to Paroxetine in the Treatment of Major Depressive Disorder
Appelhof, B. C., Brouwer, J. P., van Dyck, R., Fliers, E., Hoogendijk, W. J. G., Huyser, J., Schene, A. H., Tijssen, J. G. P., & Wiersinga, W. M. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1147 · Cited by 62
Fluoxetine Compared with Imipramine in the Treatment of Inpatient Depression A Multicenter Trial
Beasley, C. M., Holman, S., & Potvin, J. H. (1993) · Annals of Clinical Psychiatry · doi:10.3109/10401239309148983 · Cited by 60
Mirtazapine: clinical overview.
Gorman, J. M. (1999) · PubMed · Cited by 57
Clinical efficacy of milnacipran
Lecrubier, Y., Plétan, Y., Solles, A., Tournoux, A., & Magne, V. (1996) · International Clinical Psychopharmacology · doi:10.1097/00004850-199609004-00004 · Cited by 57
Moclobemide and Tricyclic Antidepressants in Severe Depression
Angst, J., Amrein, R., & Stabl, M. (1995) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199508001-00004 · Cited by 57
Guelfi, J., Ansseau, M., Corruble, E., Samuelian, J., Tonelli, I., Tournoux, A., & Plétan, Y. (1998) · International Clinical Psychopharmacology · doi:10.1097/00004850-199805000-00005 · Cited by 56
Rush, A. J., Koran, L. M., Keller, M. B., Markowitz, J. C., Harrison, W. M., Miceli, R. J., FAWCETT, J. A., Gelenberg, A. J., Hirschfeld, R. M. A., Klein, D. N., et al. (1998) · PubMed · Cited by 54
Zajecka, J., Jeffries, H., & Fawcett, J. (1995) · PubMed · Cited by 53
Severity of depression and response to fluoxetine
Pande, A. C., & Sayler, M. E. (1993) · International Clinical Psychopharmacology · doi:10.1097/00004850-199300840-00006 · Cited by 51
Saletu-Zyhlarz, G. M., Anderer, P., Arnold, O., & Saletu, B. (2003) · Neuropsychobiology · doi:10.1159/000074638 · Cited by 51
Macher, J. P., Jp, S., Serre, C., von Frenckell, R., Huck, J.-C., & Demarez, J.-P. (2008) · Neuropsychobiology · doi:10.1159/000118596 · Cited by 49
Vagus nerve stimulation in depression
Goodnick, P. J., Rush, A. J., George, M. S., Marangell, L. B., & Sackeïm, H. A. (2001) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2.7.1061 · Cited by 49
A multicenter evaluation of bupropion versus placebo in hospitalized depressed patients.
Lf, F., Brodie, H. K. H., Garver, D., & Ww, Z. (1983) · PubMed · Cited by 49
The Treatment of Chronic Depression, Part 1
Rush, A. J., Koran, L. M., Keller, M. B., Markowitz, J. C., Harrison, W. M., Miceli, R. J., FAWCETT, J. A., Gelenberg, A. J., Hirschfeld, R. M. A., Klein, D. N., et al. (1998) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v59n1106 · Cited by 46
Treating depression to remission.
Zajecka, J. (2003) · PubMed · Cited by 44
Conca, A., Swoboda, E., K�nig, P., Koppi, S., Beraus, W., K�nz, A., Fritzsche, H., & Wei�, P. (2000) · Human Psychopharmacology Clinical and Experimental · Cited by 42
The Place for the Tricyclic Antidepressants in the Treatment of Depression
Boyce, P. M., & Judd, F. K. (1999) · Australian & New Zealand Journal of Psychiatry · doi:10.1046/j.1440-1614.1999.00580.x · Cited by 41
Aa, N. (1994) · PubMed · Cited by 40
Montgomery, S., & Lecrubier, Y. (1999) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(98)00048-0 · Cited by 39
The efficacy of fluvoxamine in patients with severe depression
Ottevanger, E. A. (1994) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(94)90080-9 · Cited by 39
Antidepressant effectiveness in severe depression and melancholia.
Schatzberg, A. F. (1999) · PubMed · Cited by 38
Kasper, S. F., Zivkov, M., Roes, K. C. B., & Pols, A. G. (1997) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(96)00394-x · Cited by 38
Selective serotonin reuptake inhibitor efficacy in severe and melancholic depression
Amsterdam, J. D. (1998) · Journal of Psychopharmacology · doi:10.1177/0269881198012003061 · Cited by 35
Bupropion in depression: a tri-center placebo-controlled study.
Pitts, W. M., FANN, W. E., Halaris, A. E., Dressler, D. M., Sajadi, C., Snyder, S., & Rl, I. (1983) · PubMed · Cited by 30
Treatment of severe depression
Nemeroff, C. B. (2000) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(00)90069-6 · Cited by 27
Self-citationThe impact of early trauma on response to psychotherapy
Craighead, W. E., & Nemeroff, C. B. (2005) · Clinical Neuroscience Research · doi:10.1016/j.cnr.2005.03.004 · Cited by 27
Self-citationThe Clinical Pharmacology and Use of Paroxetine, a New Selective Serotonin Reuptake Inhibitor
Nemeroff, C. B. (1994) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1994.tb02799.x · Cited by 26
Self-citationEfficacy of venlafaxine in the treatment of severe depression
Kienke, A. S., & Rosenbaum, J. F. (2000) · Depression and Anxiety · doi:10.1002/1520-6394(2000)12:1+<50::aid-da6>3.0.co;2-4 · Cited by 26
GRUNHAUS, Leon, GREDEN, & JOHN, F. (1995) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-199509000-00016 · Cited by 26
Fink, M. (1979) · The Lancet · doi:10.1016/s0140-6736(79)92317-1 · Cited by 26
The use of bupropion in hospitalized depressed patients.
Merideth, C., & Feighner, J. P. (1983) · PubMed · Cited by 25
Ottevanger, E. A. (1995) · PubMed · Cited by 23
Lithium and desipramine versus desipramine alone in the treatment of severe major depression
Cappiello, A., McDougle, C. J., Delgado, P. L., Malison, R. T., Jatlow, P., Charney, D. S., Heninger, G. R., & Price, L. H. (1998) · International Clinical Psychopharmacology · doi:10.1097/00004850-199809000-00001 · Cited by 22
Bruijn, J. A., Moleman, P., Mulder, P. G. H., & van den Broek, W. W. (1998) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v59n1203 · Cited by 21
Feiger, A. D., Flament, M. F., Boyer, P., & Gillespie, J. A. (2003) · International Clinical Psychopharmacology · doi:10.1097/00004850-200307000-00002 · Cited by 21
Selective versus multi-transmitter antidepressants: are two mechanisms better than one?
Burke, W. J. (2004) · PubMed · Cited by 21
Risk-Benefit Assessment of Newer Versus Older Monoamine Oxidase (MAO) Inhibitors
Lecrubier, Y. (1994) · Drug Safety · doi:10.2165/00002018-199410040-00003 · Cited by 20
Lépine, J. P., Goger, J., Blashko, C., Probst, C., Moles, M.-F., Kosolowski, J., Scharfetter, B., & Lane, R. M. (2000) · International Clinical Psychopharmacology · doi:10.1097/00004850-200015050-00003 · Cited by 19
Zohar, J., Keegstra, H., & Barrelet, L. (2003) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.442 · Cited by 18
Major depression: selecting safe and effective treatment.
Bhatia, S. C., & Bhatia, S. K. (1997) · PubMed · Cited by 17
Augmentation of milnacipran by risperidone in treatment for major depression
Tani, K., Takei, N., Kawai, M., Suzuki, K., Sekine, Y., Toyoda, T., Minabe, Y., & Mori, N. (2004) · The International Journal of Neuropsychopharmacology · doi:10.1017/s146114570300381x · Cited by 17
Parker, G. B., Brotchie, H., & Parker, K. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.4.796 · Cited by 13
Essentials of Clinical Psychopharmacology, 2001.
B, E. B. (2001) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-200111000-00018 · Cited by 13
Hawley, C. J., Quick, S., HARDING, M. J., Pattinson, H. A., & Sivakumaran, T. (1997) · Europe PMC (PubMed Central) · Cited by 9
P.1.199 Remission rates following therapy with bupropion or selective serotonin reuptake inhibitors
Thase, M. E., Wang, Y., Richard, N., Mitton, M. W., Haight, B., & Goodale, E. P. (2003) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(03)91909-2 · Cited by 4
Cited by
Lefaucheur, J.-P., André-Obadia, N., Antal, A., Ayache, S. S., Baeken, C., Benninger, D. H., Cantello, R. M., Cincotta, M., de Carvalho, M., De Ridder, D., et al. (2014) · Clinical Neurophysiology · doi:10.1016/j.clinph.2014.05.021 · Cited by 2,119
Avenevoli, S., Swendsen, J., He, J.-P., Burstein, M., & Merikangas, K. R. (2015) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2014.10.010 · Cited by 1,202
Schmidt, H. D., & Duman, R. S. (2007) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3282ee2aa8 · Cited by 648
McKnight, P. E., & Kashdan, T. B. (2009) · Clinical Psychology Review · doi:10.1016/j.cpr.2009.01.005 · Cited by 400
“Cut scores for symptom measures are routinely analyzed to determine optimal cut points that may indicate remission (e.g., Nemeroff, 2007).”
BackgroundNeurobiology of depression: an integrated view of key findings
Maletic, V., Robinson, M., Oakes, T., Iyengar, S., Ball, S. G., & Russell, J. (2007) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2007.01602.x · Cited by 382
Metadata
- Authors
- Nemeroff, C. B.
- Venue
- Journal of Psychiatric Research
- Publisher
- Elsevier BV
- Published
- 2007-04
- Volume
- 41
- Issue
- 3-4
- Pages
- 189-206
- ISSN
- 0022-3956 (ISSN-L)
- OpenAlex
- W2158562888
- Cited by
- 295
- References
- 152
- FWCI
- 7.74
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.